ALUR logo

Allurion Technologies Inc. Stock Price

NYSE:ALUR Community·US$16.8m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 11 Fair Values set on narratives written by author
Create a narrative

ALUR Share Price Performance

US$2.11
-15.52 (-88.03%)
86.8% undervalued intrinsic discount
US$16.00
Fair Value
US$2.11
-15.52 (-88.03%)
86.8% undervalued intrinsic discount
US$16.00
Fair Value
Price US$2.11
AnalystHighTarget US$16.00
AnalystConsensusTarget US$5.83
AnalystLowTarget US$2.50

ALUR Community Narratives

AnalystHighTarget·
Fair Value US$16 86.4% undervalued intrinsic discount

Global Obesity Trends And Telemedicine Will Accelerate Non-invasive Weight Loss

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$5.83 62.8% undervalued intrinsic discount

Expanding Obesity Solutions Will Boost Prospects Amid Launch Uncertainties

0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AnalystLowTarget·
Fair Value US$2.5 13.2% undervalued intrinsic discount

Distributor Disruptions And FDA Delays Will Permit Modest Rebound

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent ALUR News & Updates

User avatar

Low-dose GLP-1 Combo And FDA Approval Will Expand Obesity Care

The combination therapy approach and clinical advancements are set to drive increased revenue and expand market share in obesity and related treatments.

Allurion Technologies Inc. Key Details

US$19.9m

Revenue

US$7.6m

Cost of Revenue

US$12.3m

Gross Profit

US$43.0m

Other Expenses

-US$30.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-3.95
Gross Margin
61.77%
Net Profit Margin
-153.93%
Debt/Equity Ratio
-111.2%

Allurion Technologies Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 
View more competitors

Snowflake Analysis

Moderate risk and slightly overvalued.

5 Risks
2 Rewards
View Full Analysis

About ALUR

Founded
n/a
Employees
136
CEO
Shantanu Gaur
WebsiteView website
www.allurion.com

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

Market Insight

Header cover image

📈 Markets Break Records: Q3 2025 in Review, Q4 Outlook Ahead

Richard Bowman avatarRichard Bowman
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Last Week
✨Rare Earths: Tiny Market, Outsized Influence

✨Rare Earths: Tiny Market, Outsized Influence

U.S. Market Performance

  • 7 Days: 0.8%
  • 3 Months: 8.3%
  • 1 Year: 17.8%
  • Year to Date: 15.4%
Over the last 7 days, the market has remained flat, although notably the Utilities sector gained 3.1% in that time. More promisingly, the market is up 18% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›